| Literature DB >> 24744464 |
Roshan V Dabidi1, S Hosseinzadeh2, S Mahjoub3, M Hosseinzadeh4, J Myers5.
Abstract
Lead is a highly neurotoxic agent that particularly affects the developing central nervous system. In the current study we investigated the neuroprotective effects of exercise training and/or diferuloyl methane (DM) supplement, which is known as curcumin, on lead acetate-induced neurotoxicity in the rat hippocampus. Sixty rats were randomly divided into six groups: 1) lead acetate, 2) DM supplement, 3) endurance training, 4) training+ DM supplement, 5) sham and 6) base. The rats in the training groups performed treadmill running consisting of 15 to 22 m · min(-1) for 25 to 64 min, 5 times a week for 8 weeks. All groups except sham received lead acetate (20 mg · kg(-1)), whereas the sham group received DM solvent. In addition, the DM and training + DM groups received DM solution (30 mg · kg(-1)) intraperitoneally. Chronic administration of lead acetate resulted in a significant increase in the malondialdehyde (MDA) in plasma, but not in the hippocampus. In addition, it led to significantly decreased brain-derived neurotrophic factor (BDNF) in the hippocampus and total antioxidant capacity (TAC) levels, as compared to the sham group. Treadmill running, DM supplementation, or both resulted in a significant decrease in MDA levels and significantly increased BDNF and TAC levels, as compared to the lead acetate group. These results provide a rationale for an inhibitory role of DM supplement and regular exercise in the attenuation of lead-induced neurotoxicity.Entities:
Keywords: BDNF; diferuloyl methane supplement; endurance exercise; lead; oxidative stress
Year: 2013 PMID: 24744464 PMCID: PMC3944559 DOI: 10.5604/20831862.1029820
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
EFFECTIVENESS OF THE 8-WEEK TRAINING AND SUPPLEMENTATION PROTOCOLS ON BODY MASS, BRAIN MASS, AND BRAIN-BODY MASS RATIO IN RATS CHRONICALLY EXPOSED TO LEAD ACETATE.
| Markers | B | SH | L | TL | DML. | DMTL. |
|---|---|---|---|---|---|---|
| Body mass (g) | 342 ± 25 | 341 ± 34 | 306 ± 33 | 328 ± 20 | 322 ± 22 | 343 ± 34 |
| Brain mass (g) | 1.738 ± 0.149 | 1.705 ± 0.149 | 1.618 ± 0.192 | 1.765 ± 0.209 | 1.723 ± 0.101 | 1.794 ± 0.185 |
| Brain/body mass ratio | 0.0053 ± 0.006 | 0.0051 ± 0.005 | 0.0053 ± 0.006 | 0.0049 ± 0.011 | 0.0054 ± 0.005 | 0.0052 ± 0.054 |
Note: Values are means ± SD for 8 rats; Abbreviations: B (base); SH (Sham); L (Lead); TL (Training + Lead); DML. (DM supplement + Lead); DMTL. (DM supplement + Training + Lead) groups.
Significant difference compared to lead acetate group (p < 0.05).
FIG. 1HIPPOCAMPUS BDNF CONCENTRATIONS IN EXPERIMENTAL ANIMALS
Note: Statistical significance p < 0.05; * Significant difference compared to the control groups (base and sham); # Significant difference compared to the lead group. Abbreviations: B (base); SH (Sham); L (Lead); TL (Training + Lead); DM.L. (DM supplement + Lead); DM.T.L. (DM supplement + Training + Lead) groups.
FIG. 3SHOWS MDA:TAC RATIO CONCENTRATIONS IN PLASMA IN EXPERIMENTAL ANIMALS
Note: * Significant difference compared to the control groups (base and sham); # more significant than in the lead group. Abbreviations;: B (base); SH (Sham); L (Lead); TL (Training + Lead); DM.L. (DM supplement + Lead); DM.T.L. (DM supplement + Training + Lead) groups
FIG. 2HIPPOCAMPUS MDA CONCENTRATIONS IN EXPERIMENTAL ANIMALS
Note: * Significant difference compared to the control groups (base and sham); Abbreviation; s: B (base); SH (Sham); L (Lead); TL (Training + Lead); DM.L. (DM supplement + Lead); DM.T.L. (DM supplement + Training + Lead) groups.